Back

Fibrosis as Measured by the Biomarker, Tissue Inhibitor Metalloproteinase 1, Predicts Mortality in Age Gene Environment Susceptibility Reykjavik (AGES Reykjavik) Study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Registry Results 2 Biomarkers ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gina LaRocca

National Institutes of Health (NIH), Bethesda (United States of America)

5 More presentations in this session

Presentation thumbnail
Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Insights from the MAUDE Database
Associate Professor A. Kalra (Akron, US)
Slides Video
Presentation thumbnail
Prevalence of serious complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014
Professor G. Steinbeck (Starnberg, DE)
Presentation thumbnail
Implementation of modern treatments explains improvements in outcomes after ST-Elevation Myocardial Infarction (STEMI) over a 20-year period in Sweden from 1995 to 2014
Doctor K. Szummer (Stockholm, SE)
Slides Video
Presentation thumbnail
How can we explain the J curve in hypertensive patients with coronary artery disease? An analysis of 22,672 patients from the CLARIFY registry.
Doctor E. Vidal-Petiot (Paris, FR)
Slides Video
Presentation thumbnail
Effectiveness of community atrial fibrillation screening in over 10,000 citizens using smartphone electrocardiogram- The AFinder program
Doctor N. Chan (Hong Kong, HK)
Slides Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Registry Results 2

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources